A small sample study showed that preoperative treatment with cabergoline improved biochemical control in acromegaly patients, with tumor volume changes mainly observed in GH/prolactin co-secreting tumors, and less frequently in tumors that solely secrete GH (46, 47). This evidence concerns the gene PRL and neoplasm.